Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection

BACKGROUND: Gram-negative bacteria bloodstream infection (GNB-BSI) results in considerable mortality and hospitality costs in cirrhotic patients. β-lactam/β-lactamase inhibitor combinations (BLBLIs) and carbapenems (CARs) are widely recommended for treating GNB-BSI in cirrhotic patients, while the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yuzhu, Li, Ying, Zhang, Ying, Sun, Dan, Du, Qian, Zhang, Tao, Teng, Mengmeng, Han, Ruiying, Wang, Yan, Zhu, Li, Lei, Jin’e, Dong, Yalin, Wang, Taotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213871/
https://www.ncbi.nlm.nih.gov/pubmed/32440170
http://dx.doi.org/10.2147/IDR.S241648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213871/
https://www.ncbi.nlm.nih.gov/pubmed/32440170
http://dx.doi.org/10.2147/IDR.S241648

Ejemplares similares